National Health Investors (NYSE:NHI) Issues FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.430-4.440 for the period, compared to the consensus EPS estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Stock Performance

Shares of NYSE NHI traded up $2.20 during mid-day trading on Friday, hitting $81.84. The company had a trading volume of 93,006 shares, compared to its average volume of 194,321. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. The business’s 50-day simple moving average is $80.37 and its 200-day simple moving average is $73.21. National Health Investors has a 12 month low of $50.12 and a 12 month high of $86.13. The firm has a market cap of $3.56 billion, a P/E ratio of 27.09, a PEG ratio of 5.05 and a beta of 1.05.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the previous year, the business posted $1.08 EPS. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. As a group, analysts predict that National Health Investors will post 4.48 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.40%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 122.45%.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Truist Financial raised their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Finally, Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price objective for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Four analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.